and for those tesamorelin-treated patients completing the 26-week treatment period that were re-randomized to tesamorelin (T-T group) or re-randomized to placebo, 36.6% and 32.0%, respectively, had impaired glucose tolerance, while 2.0% re-randomized to tesamorelin and 6.0% re-randomized to placebo had diet-controlled diabetes mellitus
Individual Response : Results vary based on age, metabolism, diet, training routine, and natural GH levels
Add BPC-157 and AOD-9604 for intermediate protocols targeting 15-20 pound fat loss, or go full competition prep with advanced stacks including TB-500 and HGH fragments for 20-30+ pound transformations
Just three weeks into one study, glutathione supplementation was found to increase insulin sensitivity significantly, suggesting glutathione therapy could help prevent and even help treat diabetes and related conditions